Wednesday, January 27, 2010

DDP 2010: Technology Showcase Spotlight Session: Move Beyond Passive to Active Transdermal Drug Delivery Technology- Progress on the Janisys Microneed

John O'Dea, PhD, CEO, Janisys

Pump vs Patch
-Control of timing
-Any liquid formation

-Ease of use
-Limited formulations

When using this patch, the history of drug delivery can be recorded, and most drugs can be put on the patch. The value proposition lies in having a lot of different drugs available. There is 85-90% efficiency of drug projection.

Share this article with your social network, just click below to share now!

No comments :

Post a Comment